EFFECT OF IN VITRO CYCLOSPORIN A TREATMENT ON HUMAN NATURAL AND ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY
- 1 February 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 35 (2) , 127-129
- https://doi.org/10.1097/00007890-198302000-00004
Abstract
Concentrations of 0.1-10.0 .mu.g/ml cyclosporin A (Cy A) do not directly inhibit the lysis of 51Cr-labeled K-562 [human leukemia] target cells by human peripheral blood natural killer (NK) cells nor of antibody-coated chicken red blood cells by antibody-dependent cellular cytotoxicity (ADCC) effector cells. Pretreatment of effector cells with Cy A for 18 h still failed to affect NK or ADCC effector function. Induction of NK cell activity by overnight pretreatment of effector cells by polyinosinate-polycytidylate (PolyIC) was inhibited by as little as 1 .mu.g Cy A/ml. The mechanism of inhibition may involve as direct effect of Cy A on induced or activated NK cells or inhibition of the release of Poly IC-induced interferon from lymphocytes.Keywords
This publication has 12 references indexed in Scilit:
- INHIBITION OF HUMAN NATURAL KILLER ACTIVITY BY CYCLOSPORIN ATransplantation, 1981
- Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.The Journal of Immunology, 1980
- Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analogues.The Journal of Immunology, 1980
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Activation of Human Natural Killer Cells Cytotoxic for Human Leukemia Cells by Purified InterferonThe Journal of Immunology, 1979
- CYCLOSPORIN ATransplantation, 1979
- CYCLOSPORIN A FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN MANThe Lancet, 1978
- Spontaneous human lymphocyte‐mediated cytotoxicity againts tumour target cells. I. The effect of malignant diseaseInternational Journal of Cancer, 1976
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976